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Modifiable lifestyle factors such as diet, exercise, alcohol 
intake, and smoking, have well-established associations 
with risk of dementia. A poor diet, insufficient exercise, 
excessive alcohol intake, and smoking are individually 
associated with increased risk for dementia, while adhering 
to a healthy diet, abstaining from smoking, exercising 
regularly, and consuming alcohol in moderation have all 
been associated with decreased risk. However, there is a 
paucity of research regarding the cumulative impact of 
these factors on dementia risk. Moreover, studies of lifestyle 
typically have not taken into account an individual’s overall 
genetic predisposition for dementia. This is a significant 
confound given that genetic background is thought to play 
a predominant role in much of dementia. Large genome-
wide association studies (GWAS) have made substantial 
progress in unearthing susceptibility loci for dementia, but 
most of these have not been examined in conjunction with 
lifestyle (1,2). Thus, prior to the recent JAMA study by 
Lourida et al. (3), the extent to which overall lifestyle can 
offset or exacerbate an individual’s genetic risk for dementia 
had been examined only in small cohorts, and/or in the 
context of specific genetic risk factors (i.e., APOE-ε4). 
This study is the first to examine the association between 
lifestyle and dementia using a composite measure of lifestyle 
and a polygenic measure of genetic risk for dementia. 
Consequently, it provides strong evidence that modifiable, 
external factors such as lifestyle can influence dementia risk, 
regardless of genetic background. 
This retrospective study measured incident dementia in 
196,383 participants from the United Kingdom. Mean age 
of individuals at enrollment was 65.8 years for those who 
developed dementia (n=1,769), and 64.1 years for those 
who did not (n=194,614). Participants, who did not have 
prevalent dementia at study enrollment, were followed for 
approximately 8 years or until one of the following criteria 
was met: (I) diagnosis of dementia, (II) death, or (III) 
loss to follow-up. The authors generated a polygenic risk 
score based on single nucleotide polymorphisms (SNPs) 
previously identified in a GWAS (2), ultimately including 
over 200,000 SNPs associated with Alzheimer’s disease 
(AD). For each individual, the number of risk alleles per 
SNP was weighted by the strength of that SNP’s association 
with AD, and these were summed to generate an overall 
risk score. Individuals were then divided into either low, 
intermediate, or high genetic risk categories. 
Individuals were also grouped into either favorable, 
intermediate, or unfavorable lifestyles, based on self-
reported responses to a questionnaire at enrollment on 
smoking status, physical activity level, diet, and alcohol 
consumption. One significant limitation to this approach 
is that lifestyle habits measured at enrollment do not 
necessarily reflect lifestyle habits throughout life. Since 
dementia pathogenesis is thought to initiate years or even 
decades prior to manifestation of symptoms, lifestyle factors 
in mid-to-early life are arguably more or equally important 
to those later in life. A long-term prospective cohort study 
that carefully documents lifestyle habits throughout life and 
measures incident dementia would be needed to address this 
issue. Consequently, published prospective cohort studies of 
incident dementia and lifestyle factors have been restricted 
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to small sample sizes with limited statistical power. While 
retrospective studies can be an effective way to circumvent 
this barrier, it will be important for future studies that 
enroll elderly patients to establish how well lifestyle 
metrics ascertained at study entry reflect the lifestyle habits 
of previous decades. Similarly, preclinical studies using 
validated animal models of dementia may be useful in 
identifying therapeutic window(s) during which lifestyle 
factors effectively influence dementia risk.  
The key findings of the Lourida et al. study are: (I) an 
unhealthy lifestyle increases risk for dementia, independent 
of genetic risk; and (II) a healthy lifestyle can decrease risk 
for dementia, independent of genetic risk. However, it is 
important to note that for individuals with a high genetic 
risk score, following a favorable lifestyle may decrease risk 
of incident dementia, but it does not completely eliminate 
their risk for developing dementia. As noted by the authors, 
in individuals with high genetic risk of dementia, the 
difference between following a favorable vs. unfavorable 
lifestyle roughly translates to prevention of dementia in 
1/121 individuals over a 10-year period. Whether lifestyle 
habits also affected the severity or time-to-onset of 
dementia was not specifically addressed. Considering that 
this study found that the genetic contribution to dementia 
risk was decreased, but not eliminated by a healthy lifestyle, 
it is worth exploring whether therapeutics can amplify the 
effects of a favorable lifestyle in genetically susceptible 
individuals. 
Given the challenges of conducting a randomized 
controlled trial (RCT) to evaluate whether lifestyle factors, 
such as diet and exercise, modify the genetic risk of AD 
and other dementias, preclinical studies will be critical 
for generating data regarding the value of various lifestyle 
factors in influencing genetic risk. To that end, here we 
comment on recent preclinical and clinical studies of 
various non-drug interventions, and discuss their potential 
to be used as therapeutics, or in conjunction with lifestyle 
changes to mitigate dementia. 
Diet
Ketogenic diets and caloric restriction have both been 
reported to have beneficial effects on cognitive function. 
These approaches may reflect overlapping mechanisms, since 
caloric restriction effectively increases ketone bodies (4). 
Ketones and a ketogenic diet have well-established 
beneficial effects in the treatment and control of epilepsy; 
however, their benefit(s) in AD and age-related cognitive 
decline is an emerging area of research (5). In rodents, 
ketogenic studies are typically performed using exogenous 
ketones, and several studies have demonstrated improved 
cognitive function and decreased β-amyloid load in AD-
transgenic mice administered ketones (6,7). Similarly, 
a small clinical trial in humans with mild cognitive 
impairment (MCI) showed that a low-carbohydrate 
(ketogenic) diet improved verbal memory (8). While these 
data are promising, there are critical challenges associated 
with leveraging the beneficial effects of ketones as a 
therapeutic strategy for treating dementia. These include 
issues of patient compliance due to poor tolerability of long-
term ketogenic diets, although this may be improved by 
using a different type of ketone body (9,10). Perhaps more 
problematic is that long-term ketogenic diets and prolonged 
fasting may lead to or exacerbate nutritional deficits in the 
elderly (5). Therefore, it will be important to establish the 
efficacy of ketone supplementation prior to and during the 
symptomatic period. 
Probiotic supplementation 
Altered gut microbiota have been observed in multiple 
neurological conditions including dementia and AD, which 
has spurred exploration of the microbiome as a therapeutic 
target (11). Indeed, recent clinical trials of prebiotic or 
probiotic supplementation to change the microbiome have 
shown promising results in AD or MCI patients, even 
with short-term treatment (12-15). For example, one small 
exploratory study found that a 4-week probiotic treatment 
resulted in improvements in the Mini-Mental State 
Examination for cognitive impairment (14), though these 
results need to be confirmed in a RCT. Moreover, though 
clinical and preclinical studies agree that there is a general 
decrease in microbial diversity during AD (16,17), these 
changes comprise many bacterial species, and probiotic 
supplementation has not been exhaustively interrogated for 
all of these. Probiotic supplementation studies typically use 
Lactobacillus and Bifidobacterium species, as these are thought 
to decrease during AD, and are general well-tolerated by 
patients. However, it is unclear whether other species or 
more targeted supplementation would have similar beneficial 
effects. More importantly, it is not clear how probiotics are 
exerting their effects on dementia or MCI. Gut microbiota 
have been shown to produce neurotransmitters and 
peptides involved in blood-brain barrier stability, to alter 
the immune response, and to increase insulin resistance (11). 
While all of these pathways have been implicated in AD, 
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whether the effects of probiotic supplementation on 
the microbiome composition of the gut influences AD 
specifically through one of these pathways has yet to be 
shown. However, one intriguing finding from these studies 
is that peripheral immune markers of inflammation are 
often reduced with probiotic administration, suggesting that 
perhaps probiotics are mediating their effects on the brain 
via immune pathways. Consistent with these findings from 
human studies, probiotic administration to AD-transgenic 
mice reduces oxidative stress and improves AD phenotypes 
in the brain (18,19). 
Overall, probiotics are particularly intriguing as a 
therapeutic, as they are generally well-tolerated and can 
be easily administered. However, as with a ketogenic diet, 
further studies are needed to determine the dose and length 
of treatment that provide optimized benefits while ensuring 
tolerability in dementia patients.
Exercise 
Exercise is perhaps the lifestyle factor most consistently 
associated with reduced risk of dementia, and studies have 
found that the positive effect(s) of exercise hold whether 
physical activity occurs in midlife, well in advance of 
dementia symptoms (20), or whether it occurs in elderly 
patients already diagnosed with dementia (21). Though 
numerous studies have documented the benefits of 
exercise in ameliorating dementia, it is important to note 
that the mechanism by which this occurs differ with age. 
For example, exercise in midlife may have long-term 
cardiovascular benefits that ultimately reduce dementia 
risk (22), while exercise in dementia patients may increase 
neurotrophic growth factors, or ameliorate depressive 
symptoms (23,24). 
The path forward 
As Lourida et al. discuss, SNPs associated with AD affect 
various biological processes including immune function, 
lipid homeostasis, endocytic processing, and cholesterol 
transport. Thus, it is possible that stratifying individuals by 
genetic variant function may reveal more pronounced effects 
of certain lifestyle factors in mitigating genetic risk. For 
example, risk variants in TREM2 and HLA-DRB5-DBR1 are 
known to influence microglial function and inflammatory 
processes. Would probiotics that modulate inflammation be 
most efficacious in these individuals? APOE-ε4 is thought 
to play a role in cholesterol homeostasis and lipid transport. 
Would APOE-ε4 individuals benefit most from a long-
term ketogenic diet? Alternatively, perhaps the benefits 
of a healthy lifestyle are greater than the sum of its parts. 
Admittedly, the biological pathways implicated in AD and 
age-related dementias often interact with one another, 
and many AD risk genes have pleiotropic effects. Over a 
lifetime, these interactive effects are likely to be magnified, 
and thus, a single therapeutic targeting a particular 
pathway (i.e., cholesterol transport) may be ineffective, 
or only effective when the intervention is administered 
early in life. Overall, future large-scale cohort studies that 
stratify by genetic variant function will be important in 
determining whether particular lifestyle factors should be 
targeted to specific individuals. Likewise, preclinical studies 
will be essential for determining the therapeutic window 
for effective lifestyle interventions, and for determining 
whether the effects of specific genetic variants on AD can 
be uniquely targeted by particular lifestyle interventions. 
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